Finance

Beta
Lists
AVLN:NASDAQ
Avalyn Pharma Inc
$30.17
-8.35%
(-2.75) 1D
$30.17
0.00% (0.00)
After hours
Closed: Jul 1, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AVLN...
Open
$32.92
High
$32.92
Low
$29.57
Mkt. cap
1.34B
Avg. vol.
408.76K
Volume
0.00
52-wk high
$33.32
52-wk low
$24.15
No. of employees
50
Open
$32.92
High
$32.92
Low
$29.57
Mkt. cap
1.34B
Avg. vol.
408.76K
Volume
0.00
52-wk high
$33.32
52-wk low
$24.15
No. of employees
50
News stories
From sources across the web
About Avalyn Pharma Inc
CEO-
Employees50
Founded2010
HeadquartersBoston, Massachusetts, United States
SectorPharmaceutical industry
Websiteavalynpharma.com
Analyst ratings
Based on 3 analysts giving stock ratings to AVLN in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for AVLN in the last 3 months.
Highest
Current $30.17
$53.00 (+75.67%)
Average
$52.00 (+72.36%)
Lowest
$51.00 (+69.04%)
Analyst
Recommendation
Action
Price target
Projected
Date
Judah Frommer
Morgan Stanley
Buy
Maintained
$53.00
+75.7%
06/03/2026
Gavin Clark-Gartner
Evercore ISI
Buy
Initiated
$51.00
+69%
05/26/2026
Roger Song
Jefferies
Buy
Initiated
$52.00
+72.4%
05/26/2026
Last report
Jun 3, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$21.83 / -$0.48
-4,447.92%miss
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Mar 2026
Revenue
-
-
Cost of goods sold
-
-
Cost of revenue
-
-
Research and development expenses
15.32M
22.89M
Total research and development expenses
-
-
Selling, general, and admin expenses
3.40M
5.02M
Operating expense
18.72M
27.91M
Total operating expenses
18.72M
27.91M
Operating income
-18.72M
-27.91M
Other non operating income
-35.00K
13.00K
EBT including unusual items
-17.50M
-26.87M
EBT excluding unusual items
-17.50M
-26.87M
Income tax expense
-
-
Effective tax rate
-
-
Other operating expenses
-
-
Net income
-17.50M
-26.87M
Net profit margin
-
-
Earnings per share
-
-21.83
Interest and investment income
1.25M
1.12M
Interest expense
-
-98.00K
Net interest expenses
1.25M
1.03M
Depreciation and amortization charges
-
-
EBITDA
-18.71M
-27.85M
Gain or loss from assets sale
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer